Catalent (CTLT) Stock Forecast, Price Target & Predictions
CTLT Stock Forecast
Catalent stock forecast is as follows: an average price target of $63.50 (represents a 0.03% upside from CTLT’s last price of $63.48) and a rating consensus of 'Hold', based on 14 wall street analysts offering a 1-year stock forecast.
CTLT Price Target
The average price target for Catalent (CTLT) is $63.50 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $63.50 to $63.50. This represents a potential 0.03% upside from CTLT's last price of $63.48.
CTLT Analyst Ratings
According to 14 Wall Street analysts, Catalent's rating consensus is 'Hold'. The analyst rating breakdown for CTLT stock is 0 'Strong Buy' (0.00%), 5 'Buy' (35.71%), 9 'Hold' (64.29%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Catalent Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 06, 2024 | David Windley | Jefferies | $63.50 | $58.51 | 8.53% | 0.03% |
| Sep 24, 2024 | Eric Coldwell | Robert W. Baird | $63.50 | $59.75 | 6.28% | 0.03% |
| May 20, 2024 | Jacob Johnson | Stephens | $63.50 | $55.37 | 14.68% | 0.03% |
| May 19, 2023 | Sean Dodge | RBC Capital | $41.00 | $32.14 | 27.57% | -35.41% |
| May 19, 2023 | Evan Stover | Robert W. Baird | $53.00 | $32.14 | 64.90% | -16.51% |
| Feb 08, 2023 | Barclays | $82.00 | $71.58 | 14.56% | 29.17% | |
| Dec 08, 2022 | Evan Stover | Robert W. Baird | $75.00 | $44.98 | 66.76% | 18.15% |
| Aug 30, 2022 | Luke Sergott | Barclays | $125.00 | $92.28 | 35.46% | 96.91% |
| May 04, 2022 | Morgan Stanley | $132.00 | $100.94 | 30.78% | 107.94% |
The latest Catalent stock forecast, released on Nov 06, 2024 by David Windley from Jefferies, set a price target of $63.50, which represents a 8.53% increase from the stock price at the time of the forecast ($58.51), and a 0.03% increase from CTLT last price ($63.48).
Catalent Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 3 |
| Avg Price Target | - | $63.50 | $63.50 |
| Last Closing Price | $63.48 | $63.48 | $63.48 |
| Upside/Downside | -100.00% | 0.03% | 0.03% |
In the current month, the average price target of Catalent stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Catalent's last price of $63.48. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 06, 2024 | Jefferies | Hold | Hold | Hold |
| Jun 28, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jun 21, 2024 | William Blair | Market Perform | Market Perform | Hold |
| May 20, 2024 | Stephens | Equal-Weight | Equal-Weight | Hold |
| Apr 04, 2024 | UBS | Sector Perform | Sector Perform | Hold |
| Feb 20, 2024 | UBS | Sector Perform | Sector Perform | Hold |
| Feb 06, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
| Sep 05, 2023 | Bernstein | Outperform | Upgrade | |
| Sep 05, 2023 | Susquehanna | Positive | Upgrade | |
| Sep 05, 2023 | UBS | Underperform | Downgrade | |
| Sep 05, 2023 | Goldman Sachs | Buy | Upgrade | |
| Sep 05, 2023 | Wells Fargo | Equal-Weight | Downgrade | |
| Sep 05, 2023 | Piper Sandler | Neutral | Downgrade | |
| Sep 05, 2023 | Raymond James | Market Perform | Downgrade | |
| Aug 30, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Aug 30, 2023 | RBC Capital | Outperform | Outperform | Hold |
| Jun 13, 2023 | William Blair | Market Perform | Market Perform | Hold |
| May 19, 2023 | RBC Capital | Outperform | Outperform | Hold |
| Apr 10, 2023 | Deutsche Bank | Hold | Buy | Upgrade |
| Feb 08, 2023 | Barclays | Overweight | Overweight | Hold |
| Aug 30, 2022 | Barclays | Buy | Buy | Hold |
| Aug 30, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
| Aug 30, 2022 | Barclays | Overweight | Overweight | Hold |
| Aug 30, 2022 | Deutsche Bank | Hold | Hold | Hold |
| Aug 30, 2022 | RBC Capital | Outperform | Outperform | Hold |
Catalent's last stock rating was published by Jefferies on Nov 06, 2024. The company gave CTLT a "Hold" rating, the same as its previous rate.
Catalent Financial Forecast
Catalent Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $1.03B | $982.00M | $1.07B | $1.04B | $1.15B | $1.02B | $1.31B | $1.27B | $1.22B | $1.02B | $1.19B | $1.05B | $910.80M | $845.70M | $947.60M | $760.60M | $721.40M | $664.70M | $725.70M | $617.50M |
| Avg Forecast | $1.43B | $1.26B | $1.21B | $1.12B | $1.35B | $1.16B | $1.11B | $1.06B | $1.22B | $1.12B | $1.01B | $934.96M | $1.05B | $952.66M | $1.12B | $1.08B | $1.33B | $1.22B | $1.15B | $1.03B | $1.14B | $989.11M | $892.45M | $811.37M | $895.51M | $692.53M | $700.81M | $636.72M | $721.03M | $644.07M |
| High Forecast | $1.45B | $1.27B | $1.23B | $1.13B | $1.36B | $1.17B | $1.14B | $1.07B | $1.22B | $1.12B | $1.05B | $975.44M | $1.07B | $965.39M | $1.14B | $1.08B | $1.33B | $1.22B | $1.15B | $1.03B | $1.14B | $989.11M | $892.45M | $811.37M | $895.51M | $692.53M | $700.81M | $636.72M | $721.03M | $644.07M |
| Low Forecast | $1.41B | $1.24B | $1.20B | $1.10B | $1.33B | $1.15B | $1.08B | $1.04B | $1.22B | $1.12B | $988.42M | $834.33M | $1.04B | $940.32M | $1.11B | $1.08B | $1.33B | $1.22B | $1.15B | $1.03B | $1.14B | $989.11M | $892.45M | $811.37M | $895.51M | $692.53M | $700.81M | $636.72M | $721.03M | $644.07M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.05% | 1.01% | 1.09% | 1.02% | 0.95% | 0.99% | 1.04% | 1.06% | 0.99% | 1.04% | 1.06% | 1.02% | 1.04% | 1.06% | 1.10% | 1.03% | 1.04% | 1.01% | 0.96% |
Catalent's average Quarter revenue forecast for Mar 24 based on 4 analysts is $1.12B, with a low forecast of $1.12B, and a high forecast of $1.12B. CTLT's average Quarter revenue forecast represents a 8.76% increase compared to the company's last Quarter revenue of $1.03B (Dec 23).
Catalent EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-111.00M | $-48.00M | $-96.00M | $-235.00M | $239.00M | $159.00M | $243.00M | $312.00M | $245.00M | $210.00M | $326.40M | $419.90M | $205.90M | $161.80M | $265.90M | $128.90M | $155.30M | $90.10M | $160.00M | $135.40M |
| Avg Forecast | $202.55M | $177.59M | $171.46M | $157.84M | $190.14M | $163.41M | $156.17M | $149.58M | $172.98M | $333.03M | $142.52M | $132.13M | $148.84M | $302.76M | $246.77M | $129.98M | $160.05M | $275.23M | $138.69M | $124.80M | $137.44M | $374.51M | $107.64M | $97.86M | $108.01M | $123.53M | $84.53M | $76.80M | $86.97M | $126.57M |
| High Forecast | $205.26M | $179.96M | $173.75M | $159.95M | $192.68M | $164.82M | $160.43M | $151.58M | $173.00M | $399.64M | $148.16M | $137.85M | $150.83M | $363.31M | $296.13M | $129.98M | $160.05M | $330.28M | $138.69M | $124.80M | $137.44M | $449.41M | $107.64M | $97.86M | $108.01M | $148.23M | $84.53M | $76.80M | $86.97M | $151.88M |
| Low Forecast | $199.93M | $175.29M | $169.24M | $155.80M | $187.68M | $162.01M | $153.33M | $147.64M | $172.96M | $266.43M | $139.69M | $117.91M | $146.91M | $242.21M | $197.42M | $129.98M | $160.05M | $220.19M | $138.69M | $124.80M | $137.44M | $299.60M | $107.64M | $97.86M | $108.01M | $98.82M | $84.53M | $76.80M | $86.97M | $101.26M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | -0.78% | -0.36% | -0.64% | -0.78% | 0.97% | 1.22% | 1.52% | 1.13% | 1.77% | 1.68% | 2.37% | 1.12% | 1.91% | 1.65% | 2.46% | 1.04% | 1.84% | 1.17% | 1.84% | 1.07% |
9 analysts predict CTLT's average Quarter EBITDA for Mar 23 to be $302.76M, with a high of $363.31M and a low of $242.21M. This is 26.68% upper than Catalent's previous annual EBITDA (Dec 22) of $239.00M.
Catalent Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-204.00M | $-715.00M | $-86.00M | $-227.00M | $81.00M | - | $188.00M | $141.00M | $97.00M | $93.00M | $182.40M | $231.80M | $88.40M | $82.40M | $154.20M | $20.90M | $45.50M | $100.00K | $65.70M | $31.70M |
| Avg Forecast | $164.71M | $73.71M | $43.68M | $4.55M | $132.30M | $52.94M | $23.50M | $8.23M | $84.94M | $152.46M | $-3.86M | $-24.84M | $19.86M | $138.60M | $97.70M | $102.15M | $210.76M | $126.00M | $152.67M | $118.95M | $201.18M | $206.74M | $101.38M | $67.28M | $144.41M | $20.03M | $81.59M | $44.21M | $118.01M | $29.63M |
| High Forecast | $167.57M | $74.99M | $44.44M | $4.63M | $134.59M | $71.14M | $53.71M | $8.37M | $84.97M | $182.95M | $1.29M | $-9.55M | $20.21M | $166.32M | $117.24M | $102.15M | $211.03M | $151.20M | $152.67M | $118.95M | $209.24M | $248.09M | $101.38M | $67.28M | $144.41M | $24.03M | $81.59M | $44.21M | $118.01M | $35.56M |
| Low Forecast | $161.94M | $72.47M | $42.94M | $4.47M | $130.07M | $39.70M | $6.71M | $8.09M | $84.92M | $121.97M | $-10.30M | $-38.22M | $19.52M | $110.88M | $78.16M | $102.15M | $210.49M | $100.80M | $152.67M | $118.95M | $193.12M | $165.39M | $101.38M | $67.28M | $144.41M | $16.02M | $81.59M | $44.21M | $118.01M | $23.71M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 52.80% | 28.78% | -4.33% | -1.64% | 0.83% | - | 0.89% | 1.12% | 0.64% | 0.78% | 0.91% | 1.12% | 0.87% | 1.22% | 1.07% | 1.04% | 0.56% | 0.00% | 0.56% | 1.07% |
Catalent's average Quarter net income forecast for Mar 23 is $138.60M, with a range of $110.88M to $166.32M. CTLT's average Quarter net income forecast represents a 71.11% increase compared to the company's last Quarter net income of $81.00M (Dec 22).
Catalent SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $239.00M | $215.00M | $219.00M | $190.00M | $226.00M | $196.00M | $226.00M | $207.00M | $228.00M | $183.00M | $184.10M | $172.70M | $165.50M | $164.70M | $158.00M | $136.10M | $141.00M | $142.80M | $143.40M | $129.90M |
| Avg Forecast | $269.79M | $236.54M | $228.38M | $210.24M | $253.26M | $217.66M | $208.01M | $199.23M | $230.40M | $223.82M | $189.83M | $175.99M | $198.25M | $203.48M | $229.65M | $195.18M | $240.33M | $184.98M | $208.25M | $187.39M | $206.37M | $154.03M | $161.63M | $146.95M | $162.19M | $130.43M | $126.93M | $115.32M | $130.59M | $121.43M |
| High Forecast | $273.39M | $239.70M | $231.43M | $213.05M | $256.64M | $219.54M | $213.68M | $201.89M | $230.42M | $268.59M | $197.35M | $183.61M | $200.89M | $244.17M | $275.58M | $195.18M | $240.33M | $221.97M | $208.25M | $187.39M | $206.37M | $184.84M | $161.63M | $146.95M | $162.19M | $156.51M | $126.93M | $115.32M | $130.59M | $145.71M |
| Low Forecast | $266.29M | $233.47M | $225.42M | $207.52M | $249.98M | $215.78M | $204.23M | $196.65M | $230.37M | $179.06M | $186.05M | $157.05M | $195.68M | $162.78M | $183.72M | $195.18M | $240.33M | $147.98M | $208.25M | $187.39M | $206.37M | $123.22M | $161.63M | $146.95M | $162.19M | $104.34M | $126.93M | $115.32M | $130.59M | $97.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.26% | 1.22% | 1.10% | 0.93% | 0.98% | 1.00% | 0.94% | 1.12% | 1.09% | 0.98% | 0.89% | 1.12% | 1.02% | 1.12% | 0.97% | 1.04% | 1.11% | 1.24% | 1.10% | 1.07% |
Catalent's average Quarter SG&A projection for Mar 24 is $223.82M, based on 4 Wall Street analysts, with a range of $179.06M to $268.59M. The forecast indicates a -6.35% fall compared to CTLT last annual SG&A of $239.00M (Dec 23).
Catalent EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-1.12 | $-3.95 | $-0.48 | $-1.25 | $0.45 | - | $1.04 | $0.78 | $0.55 | $0.49 | $0.98 | $1.27 | $0.46 | $0.42 | $0.86 | $0.08 | $0.23 | - | $0.45 | $0.22 |
| Avg Forecast | $0.91 | $0.41 | $0.24 | $0.03 | $0.73 | $0.29 | $0.13 | $0.05 | $0.47 | $0.22 | $-0.02 | $-0.14 | $0.11 | $-0.07 | $0.69 | $0.56 | $1.15 | $0.94 | $0.83 | $0.65 | $1.10 | $0.74 | $0.55 | $0.37 | $0.79 | $0.48 | $0.45 | $0.24 | $0.64 | $0.46 |
| High Forecast | $0.92 | $0.41 | $0.24 | $0.03 | $0.74 | $0.39 | $0.30 | $0.05 | $0.47 | $0.22 | $0.01 | $-0.05 | $0.11 | $-0.07 | $0.70 | $0.56 | $1.15 | $0.94 | $0.83 | $0.65 | $1.14 | $0.74 | $0.55 | $0.37 | $0.79 | $0.48 | $0.45 | $0.24 | $0.64 | $0.46 |
| Low Forecast | $0.89 | $0.40 | $0.24 | $0.02 | $0.71 | $0.22 | $0.04 | $0.04 | $0.47 | $0.22 | $-0.06 | $-0.21 | $0.11 | $-0.07 | $0.68 | $0.56 | $1.15 | $0.94 | $0.83 | $0.65 | $1.06 | $0.74 | $0.55 | $0.37 | $0.79 | $0.48 | $0.45 | $0.24 | $0.64 | $0.46 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 52.76% | 28.94% | -4.40% | 17.76% | 0.65% | - | 0.90% | 0.83% | 0.66% | 0.75% | 0.89% | 1.72% | 0.83% | 1.14% | 1.09% | 0.17% | 0.52% | 0.00% | 0.70% | 0.48% |
According to 9 Wall Street analysts, Catalent's projected average Quarter EPS for Mar 23 is $-0.07, with a low estimate of $-0.07 and a high estimate of $-0.07. This represents a -115.64% decrease compared to CTLT previous annual EPS of $0.45 (Dec 22).
Catalent Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TFX | Teleflex | $178.28 | $254.50 | 42.75% | Buy |
| IQV | IQVIA | $196.64 | $252.80 | 28.56% | Buy |
| BIO | Bio-Rad Laboratories | $337.85 | $400.00 | 18.40% | Buy |
| WST | West Pharmaceutical Services | $334.26 | $393.00 | 17.57% | Buy |
| CRL | Charles River Laboratories | $189.33 | $209.00 | 10.39% | Buy |
| CTLT | Catalent | $63.48 | $63.50 | 0.03% | Hold |